Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

daleedwards99 2 posts  |  Last Activity: Dec 20, 2015 12:11 PM Member since: May 16, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Dec 18/15 Dec 17/15 Mellon, James Direct Ownership Common Shares 10 - Acquisition in the public market 406,000 @ $0.100USD. I have spoken to a chap in Canada he says the insiders as a whole own more than 50% of the Company. Astonishing brilliant.

  • TORONTO, Dec. 14, 2015 /PRNewswire/ - The Offerors, announced that they have acquired an aggregate of 494,000 common shares of Portage. These common shares represent approximately 0.2% of the issued and outstanding common shares of Portage (based upon the 245,438,894 common shares stated to be issued and outstanding as at November 24, 2015, by Portage in its management's discussion and analysis for the three months ended September 30, 2015 (the "Q2 MD&A") filed on SEDAR on November 26, 2015. These common shares were purchased by the Offerors through the facilities of the OTC Markets and CSE for an average price of $0.13 (US$0.098) per share.

    After giving effect to the purchases described in Section (2) above, Offerors now have ownership and control over 85,078,042 common shares of Portage, representing approximately 34.66% of the outstanding common shares of Portage (based upon 245,438,894 common shares stated to be issued and outstanding as at November 24, 2015 by Portage in the Q2 MD&A). After giving effect to the purchases noted above, Offerors, together with another joint actor, Dr. Declan Doogan, now have ownership and control over 113,389,110 common shares of Portage, representing approximately 46.20% of the outstanding common shares of Portage (based upon 245,438,894 common shares stated to be issued and outstanding as at November 24, 2015 by Portage in the Q2 MD&A).

    The Offerors hold the common shares of Portage noted above for investment purposes. The Offerors may, from time to time on an individual or joint basis in the future, directly or indirectly acquire ownership of or control over additional securities of Portage. Dr. Declan Doogan, CEO and a director of Portage, who may be considered to be acting jointly or in concert with the Offerors, may, from time to time on an individual or joint basis in the future, directly or indirectly acquire ownership of or control over common shares of Portage.

    The 494,000 common shares the Offerors acquired pursuant

PFE
29.03+0.03(+0.10%)Feb 5 4:02 PMEST